Deborah Francis

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen

Aman U. Buzdar, Vicente Valero, Nuhad K. Ibrahim et al. · Clinical Cancer Research · 2007 · 466 citations

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

Edgardo Rivera, Christina Meyers, Morris D. Groves et al. · Cancer · 2006 · 153 citations · Full text

Pilot Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of the Combination of Exemestane and Tamoxifen

Edgardo Rivera, Vicente Valero, Deborah Francis et al. · Clinical Cancer Research · 2004 · 18 citations · Full text